Effect of Decaffeinated Coffee‑enriched Chlorogenic Acid on Blood Glucose Levels in Healthy Controls: A Systematic Review

Hossein Faraji

Abstract


As an important group of health problems, glucose metabolism disorders are associated with a number of diseases as well as mortality rate. Recently, studies have demonstrated that the consumption of decaffeinated coffee‑enriched chlorogenic acid (CGA) can reduce the risk of diabetes and blood glucose rise, while the results of some previous studies have shown an opposite effect. Hence, a systematic search was conducted based on literature search and appropriate keywords through PubMed, Google Scholar, Web of Knowledge, Science direct, Medline, Cochrane, and Scopus databases from 2003 to 2018. After searching, 1593 articles were found. Then, we excluded papers based on the duplication and relevant for title and abstract, whereas 25 relevant articles remained for checking eligibility criteria. Since only randomized clinical trials studies (RCTs) could be included in the current study, six RCTs remained in end‑stage for qualitative synthesis. The results of reviewed studies showed no signifcant effect of decaffeinated coffee‑enriched CGA on blood glucose concentration. Although recent studies have suggested the effectiveness of decaffeinated coffee‑enriched CGA on blood glucose in animals, and there are various mechanisms for this effect, and the result of our review showed that there is not suffcient evidence for this claim in healthy humans. Hence, further research in this area seems necessary.


Keywords


Blood glucose; chlorogenic acid; coffee; decaffeinated coffee; diabetes mellitus

Full Text:

PDF

References


Cheung NW, Napier B, Zaccaria C, Fletcher JP. Hyperglycemia

is associated with adverse outcomes in patients receiving total

parenteral nutrition. Diabetes Care 2005;28:2367‑71.

Crane PK, Walker R, Hubbard RA, Li G, Nathan DM, Zheng H,

et al. Glucose levels and risk of dementia. N Engl J Med

;369:540‑8.

McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J,

Marrie TJ. The relation between hyperglycemia and outcomes in

,471 patients admitted to the hospital with community‑acquired

pneumonia. Diabetes Care 2005;28:810‑5.

Hurst C, Thinkhamrop B, Tran HT. The association between

hypertension comorbidity and microvascular complications in

type 2 diabetes patients: A nationwide cross‑sectional study in

Thailand. Diabetes Metab J 2015;39:395‑404.

van Dam RM, Willett WC, Manson JE, Hu FB. Coffee, caffeine,

and risk of type 2 diabetes: A prospective cohort study in younger

and middle‑aged U.S. Women. Diabetes Care 2006;29:398‑403.

van Dam RM, Hu FB. Coffee consumption and risk of type 2

diabetes: A systematic review. JAMA 2005;294:97‑104.

Monteiro M, Farah A, Perrone D, Trugo LC, Donangelo C.

Chlorogenic acid compounds from coffee are differentially

absorbed and metabolized in humans. J Nutr 2007;137:2196‑201.

Meng S, Cao J, Feng Q, Peng J, Hu Y. Roles of chlorogenic

acid on regulating glucose and lipids metabolism: A review. Evid

Based Complement Alternat Med 2013;2013:801457.

Johnston KL, Clifford MN, Morgan LM. Coffee acutely modifies

gastrointestinal hormone secretion and glucose tolerance in

humans: Glycemic effects of chlorogenic acid and caffeine. Am J

Clin Nutr 2003;78:728‑33.

Lin M, Gong W, Chen Q, Sun L, Wang Y, Fan X. Evaluation of

the potential sensitization of chlorogenic acid: A meta‑analysis.

Evid Based Complement Alternat Med 2013;2013:208467.

Rodriguez de Sotillo DV, Hadley M. Chlorogenic acid modifies

plasma and liver concentrations of: Cholesterol, triacylglycerol, and

minerals in (fa/fa) Zucker rats. J Nutr Biochem 2002;13:717‑26.

Bassoli BK, Cassolla P, Borba‑Murad GR, Constantin J,

Salgueiro‑Pagadigorria CL, Bazotte RB, et al. Chlorogenic acid

reduces the plasma glucose peak in the oral glucose tolerance

test: Effects on hepatic glucose release and glycaemia. Cell

Biochem Funct 2008;26:320‑8.

McCarty MF. A chlorogenic acid‑induced increase in GLP‑1

production may mediate the impact of heavy coffee consumption

on diabetes risk. Med Hypotheses 2005;64:848‑53.

Hemmerle H, Burger HJ, Below P, Schubert G, Rippel R,

Schindler PW, et al. Chlorogenic acid and synthetic chlorogenic

acid derivatives: Novel inhibitors of hepatic glucose‑6‑phosphate

translocase. J Med Chem 1997;40:137‑45.

Ong KW, Hsu A, Tan BK. Anti‑diabetic and anti‑lipidemic

effects of chlorogenic acid are mediated by ampk activation.

Biochem Pharmacol 2013;85:1341‑51.

Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA

Group. Preferred reporting items for systematic reviews and

meta‑analyses: The PRISMA statement. BMJ 2009;339:b2535.

Clark HD, Wells GA, Huët C, McAlister FA, Salmi LR,

Fergusson D, et al. Assessing the quality of randomized trials:

Reliability of the Jadad scale. Control Clin Trials 1999;20:448‑52.

van Dijk AE, Olthof MR, Meeuse JC, Seebus E, Heine RJ,

van Dam RM. Acute effects of decaffeinated coffee and the

major coffee components chlorogenic acid and trigonelline on

glucose tolerance. Diabetes Care 2009;32:1023‑5.

Wedick NM, Brennan AM, Sun Q, Hu FB, Mantzoros CS,

van Dam RM. Effects of caffeinated and decaffeinated coffee

on biological risk factors for type 2 diabetes: A randomized

controlled trial. Nutr J 2011;10:93.

Ohnaka K, Ikeda M, Maki T, Okada T, Shimazoe T, Adachi M,

et al. Effects of 16‑week consumption of caffeinated and

decaffeinated instant coffee on glucose metabolism in a

randomized controlled trial. J Nutr Metab 2012;2012:207426.

Thom E. The effect of chlorogenic acid enriched coffee on

glucose absorption in healthy volunteers and its effect on body

mass when used long‑term in overweight and obese people. J Int

Med Res 2007;35:900‑8.

Greenberg JA, Owen DR, Geliebter A. Decaffeinated coffee

and glucose metabolism in young men. Diabetes Care

;33:278‑80.

Kuwata H, Iwasaki M, Shimizu S, Minami K, Maeda H, Seino S,

et al. Meal sequence and glucose excursion, gastric emptying and

incretin secretion in type 2 diabetes: A randomised, controlled

crossover, exploratory trial. Diabetologia 2016;59:453‑61.

Ussar S, Haering MF, Fujisaka S, Lutter D, Lee KY, Li N, et al.

Regulation of glucose uptake and enteroendocrine function by the

intestinal epithelial insulin receptor. Diabetes 2017;66:886‑96.

Rehfeld JF. Gastrointestinal hormone research – With a

Scandinavian annotation. Scand J Gastroenterol 2015;50:668‑79.

Gautier JF, Choukem SP, Girard J. Physiology of incretins (GIP

and GLP‑1) and abnormalities in type 2 diabetes. Diabetes

Metab 2008;34 Suppl 2:S65‑72.

Palatini P. Coffee consumption and risk of type 2 diabetes.

Diabetologia 2015;58:199‑200.

Jokura H, Watanabe I, Umeda M, Hase T, Shimotoyodome A.

Coffee polyphenol consumption improves postprandial

hyperglycemia associated with impaired vascular endothelial

function in healthy male adults. Nutr Res 2015;35:873‑81.

Ochiai R, Sugiura Y, Shioya Y, Otsuka K, Katsuragi Y,

Hashiguchi T. Coffee polyphenols improve peripheral endothelial

function after glucose loading in healthy male adults. Nutr Res

;34:155‑9.

Tunnicliffe JM, Eller LK, Reimer RA, Hittel DS, Shearer J.

Chlorogenic acid differentially affects postprandial glucose and

glucose‑dependent insulinotropic polypeptide response in rats.

Appl Physiol Nutr Metab 2011;36:650‑9.

Ding M, Bhupathiraju SN, Chen M, van Dam RM, Hu FB.

Caffeinated and decaffeinated coffee consumption and risk

of type 2 diabetes: A systematic review and a dose‑response

meta‑analysis. Diabetes Care 2014;37:569‑86.